Valuation Genix Pharmaceuticals Corporation Toronto S.E.

Stocks

Delayed Toronto S.E. 17:00:00 2021-10-04 EDT			5-day change	1st Jan Change
0.1700 ^CAD	-.--%		-.--%	-

06-27	Genix Pharmaceuticals Corporation Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2026	CI
05-05	Genix Pharmaceuticals Corporation Announces Chief Financial Officer Changes	CI

Data adjusted to current consolidation scope

Fiscal Period: October	2020	2021	2022	2023	2024	2025
Market Cap ¹	9.803	8.884	3.85	2.369	2.961	1.837
Change	-	-9.37%	-56.67%	-38.46%	25%	-37.97%
Enterprise Value (EV) ¹	9.121	8.794	4.023	2.869	3.765	2.836
Change	-	-3.59%	-54.25%	-28.69%	31.25%	-24.68%
P/E	-11.5x	-5.38x	-3.58x	-0.54x	-40.5x	-5.33x
PBR	2.01x	2.21x	1.2x	-2.08x	-2.5x	-1.29x
PEG	-	-0.1x	0.1x	-0x	0.4x	-0x
Capitalization / Revenue	-	-	-	191,865,635x	730,981,486x	-
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-28.9x	-8.05x	-8.82x	-9.92x	20.7x	-22.7x
EV / EBIT	-13.5x	-5.45x	-4.03x	-3.45x	-10.3x	-22.5x
EV / FCF	31.7x	13x	23.4x	47.6x	-7.06x	-18.8x
FCF Yield	3.16%	7.7%	4.28%	2.1%	-14.2%	-5.32%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0144	-0.0279	-0.0181	-0.0742	-0.001235	-0.005627
Distribution rate	-	-	-	-	-	-
Net sales	-	-	-	0.0123	0.004051	-
EBITDA ¹	-0.3156	-1.092	-0.4559	-0.2893	0.1822	-0.1248
EBIT ¹	-0.6767	-1.615	-0.9984	-0.8318	-0.364	-0.126
Net income ¹	-0.7187	-1.653	-1.074	-4.396	-0.0732	-0.3351
Net Debt ¹	-0.6814	-0.0899	0.1732	0.4999	0.8042	0.9993
Reference price ²	0.1650	0.1500	0.0650	0.0400	0.0500	0.0300
Nbr of stocks (in thousands)	59,409	59,224	59,224	59,224	59,224	61,224
Announcement Date	3/1/21	2/28/22	2/28/23	2/27/24	2/26/25	2/25/26

¹CAD in Million²CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.7x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	26.61x	6.52x	17.27x	2.29%	410.8B
Weighted average by Cap.	31.80x	7.61x	18.61x	1.96%